Asia Pacific Transdermal Drug Delivery System Market to Grow at a CAGR of 4.9% to reach US$ 1,736.02 Million from 2020 to 2027

Asia Pacific Transdermal Drug Delivery System Market Forecast to 2027 - COVID-19 Impact and Analysis - by Type (Transdermal Patches, Transdermal Semisolids); Application (Cardiovascular Diseases, Central Nervous System Disorders, Pain Management, Hormonal Applications, Other Applications); End User (Hospitals and Clinics, Home Care Settings, Other End Users)

Publication Month: Aug 2020 | Report Code: TIPRE00013002 | No. of Pages: 180 | Category: Medical Device | Status: Published
Covid

The Asia Pacific transdermal drug delivery system market is expected to reach US$ 1,736.02 million by 2027 from US$ 1,199.69 million in 2019. The market is estimated to grow at a CAGR of 4.9% from 2020 to 2027.

The growth of the market is attributed to increasing prevalence of chronic diseases, growing demand for non-invasive drug delivery devices, and high demand for self-administration of drugs. However, the drug failure and recalls of transdermal drug delivery systems hinder the growth of the market in Asia Pacific.

 

The Asia Pacific transdermal drug delivery system market is expected to witness significant growth during the forecast period. The growth of the market is expected to be fastest in countries such as China, India, and Australia. The growth of the market in these countries is expected to be fastest due to growing technology, growing geriatric population, increasing prevalence of cardiovascular diseases, and growing demand for non-invasive medical devices. China is the largest market for transdermal drug delivery systems market. The growth of the transdermal drug delivery system market is primarily attributed to the growing technology in China and increasing developments by the market players. The excessive population in China, coupled with the rising prevalence of chronic diseases is offering immense growth opportunities in the transdermal patches and semisolid products for the pain management market. However, considering the geographic and economic operations between Asian countries and China, the countries are expected to witness challenge of COVID-19. The outbreak of disease has badly affected supply chain, and led to shortage of healthcare supplies in the region. Moreover, domestic start-ups backed by international funding have already started witnessing back out from investors putting the development of the products in jeopardy.

  

Asia Pacific Transdermal Drug Delivery System Market Revenue and Forecast to 2027 (US$ Million)

 

Asia Pacific Transdermal Drug Delivery System Market Revenue and Forecast to 2027 (US$ Million)

Get more information on this report :

 

Asia Pacific Transdermal Drug Delivery System Market Segmentation

 

By Type

  • Transdermal Patches
    • Matrix Patches
    • Microneedle Patches
    • Drug-In-Adhesive Patches
    • Reservoir Membrane Patches
  • Transdermal Semisolids
    • Sprays
    • Gels
    • Ointments

 

By Application

•    Cardiovascular Diseases

•     Central Nervous System Disorders

•     Pain Management

•     Hormonal Applications

    • Transdermal Estrogen Therapy
    • Testosterone Replacement Therapy

•     Other Applications

 

By End User

•    Hospitals and Clinics

•     Home Care Settings

•     Other End Users

By Country

  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Rest of Asia Pacific

 

Company Profiles

  • Novartis AG
  • Luye Pharma Group
  • Mylan N.V.
  • GlaxoSmithKline plc
  • Hisamitsu Pharmaceutical Co., Inc

 

 

1.          Introduction

1.1        Study Scope

1.2        The Insight Partners Research Report Guidance

1.3        Market Segmentation

1.3.1        Asia Pacific Transdermal Drug Delivery System Market– By Type

1.3.2        Asia Pacific Transdermal Drug Delivery System Market– By Application

1.3.3        Asia Pacific Transdermal Drug Delivery System Market– By End User

1.3.4        Asia Pacific Transdermal Drug Delivery System Market– By Region

2.          Transdermal Drug Delivery System Market –  Key Takeaways

3.          Research Methodology

3.1        Coverage

3.2        Secondary Research

3.3        Primary Research

4.          Transdermal Drug Delivery System – Market Landscape

4.1        Overview

4.2        PEST Analysis

4.2.1        Asia Pacific

4.3        Expert Opinion

5.          Asia Pacific Transdermal Drug Delivery System Market – Industry Dynamics

5.1        Key Drivers

5.1.1        Increasing Prevalence of Chronic Diseases

5.1.2        Growing Demand for Non-Invasive Drug Delivery Devices

5.1.3        High Demand for Self-Administration of Drugs

5.2        Market Restraints

5.2.1        Drug Failure and Recalls of Transdermal Drug Delivery Systems

5.3        Market Opportunities

5.3.1        Strategic Activities by the Manufacturers

5.4        Future Trends

5.4.1        Rise in Adoption of Third-Generation Delivery Systems

5.5        Impact Analysis

6.          Transdermal Drug Delivery System Market – Regional Analysis

6.1        Asia Pacific Transdermal drug delivery system Market Revenue Forecast And Analysis

7.          Transdermal Drug Delivery System Market Analysis – By Type

7.1        Overview

7.2        Transdermal Drug Delivery System Market Revenue Share, by Type, 2019 and 2027 (%)

7.2.1.1          Asia Pacific Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)

7.3        Transdermal Patch

7.3.1        Overview

7.3.2        Transdermal Patch: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)

7.3.3        Drug-In-Adhesive Patches

7.3.3.1          Overview

7.3.3.2          Drug-In-Adhesive Patches: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)

7.3.4        Matrix Patches

7.3.4.1          Overview

7.3.4.2          Matrix Patches: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)

7.3.5        Reservoir Membrane Patches

7.3.5.1          Overview

7.3.5.2          Reservoir Membrane Patches: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)

7.3.6        Microneedle Patches

7.3.6.1          Overview

7.3.6.2          Microneedle Patches: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)

7.4        Transdermal Semisolids

7.4.1        Overview

7.4.2        Transdermal Semisolids: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)

7.4.3        Gel

7.4.3.1          Overview

7.4.3.2          Gel: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)

7.5        Sprays

7.5.1        Overview

7.5.2        Sprays: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)

7.6        Ointments

7.6.1        Overview

7.6.2        Ointments: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)

8.          Transdermal Drug Delivery System Market –  By Application

8.1        Overview

8.2        Transdermal Drug Delivery System Market, by Application, 2019 and 2027 (%)

8.2.1        Asia Pacific Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2027 (USD Million)

8.3        Cardiovascular Diseases

8.3.1        Overview

8.3.2        Cardiovascular Diseases: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)

8.4        Central Nervous System Disorders

8.4.1        Overview

8.4.2        Central Nervous System Disorders: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)

8.5        Pain Management

8.5.1        Overview

8.5.2        Pain Management: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)

8.6        Hormonal Applications

8.6.1        Overview

8.6.2        Hormonal Applications: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)

8.6.3        Transdermal Estrogen Therapy

8.6.3.1          Overview

8.6.3.2          Transdermal Estrogen Therapy: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)

8.6.4        Testosterone Replacement

8.6.4.1          Overview

8.6.4.2          Testosterone Replacement: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)

8.7        Other Applications

8.7.1        Overview

8.7.2        Other Applications: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)

9.          Transdermal Drug Delivery System Market –  By End User

9.1        Overview

9.2        Transdermal Drug Delivery System Market, by End User, 2019 and 2027 (%)

9.2.1        Asia Pacific Transdermal Drug Delivery System Market, by End User – Revenue and Forecast to 2027 (USD Million)

9.3        Hospitals and Clinics

9.3.1        Overview

9.3.2        Hospitals and Clinics: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)

9.4        Home Care Settings

9.4.1        Overview

9.4.2        Home Care Settings: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)

9.5        Other End Users

9.5.1        Overview

9.5.2        Other End Users: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)

9.5.3        Other End Users: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)

10.       Transdermal Drug Delivery System Market– Regional Analysis

10.1      Asia Pacific: Transdermal Drug Delivery System Market

10.1.1     Overview

10.1.2     Asia Pacific: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (USD Million)

10.1.3     Asia Pacific Transdermal Drug Delivery Systems Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.4     Asia Pacific Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.5     Asia Pacific Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.6     Asia Pacific Transdermal Drug Delivery Systems Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.1.7     Asia Pacific Hormonal Application Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.8     Asia Pacific Transdermal Drug Delivery Systems Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.1.9     Asia Pacific: Transdermal Drug Delivery Systems Market, by Country, 2019 & 2027 (%)

10.1.10   China: Transdermal Drug Delivery Systems Market – Revenue and Forecast to 2027 (USD Million)

10.1.10.1    China: Transdermal Drug Delivery Systems Market – Revenue and Forecast to 2027 (USD Million)

10.1.10.2    China Transdermal Drug Delivery Systems Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.10.2.1    China Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.10.2.2    China Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.10.3    China Transdermal Drug Delivery Systems Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.1.10.3.1    China Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.10.4    China Transdermal Drug Delivery Systems Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.1.11   Japan: Transdermal Drug Delivery Systems Market – Revenue and Forecast to 2027 (USD Million)

10.1.11.1    Japan: Transdermal Drug Delivery Systems Market – Revenue and Forecast to 2027 (USD Million)

10.1.11.2    Japan Transdermal Drug Delivery Systems Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.11.2.1    Japan Transdermal Patches Market, by Transdermal Patches – Revenue and Forecast to 2027 (USD Million)

10.1.11.2.2    Japan Transdermal Semisolids Market, by Type– Revenue and Forecast to 2027 (USD Million)

10.1.11.3    Japan Transdermal Drug Delivery Systems Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.1.11.3.1    Japan Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.11.4    Japan Transdermal Drug Delivery Systems Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.1.12   India: Transdermal Drug Delivery Systems Market – Revenue and Forecast to 2027 (USD Million)

10.1.12.1    India: Transdermal Drug Delivery Systems Market – Revenue and Forecast to 2027 (USD Million)

10.1.12.2    India Transdermal Drug Delivery Systems Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.12.2.1    India Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.12.2.2    India Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.12.3    India Transdermal Drug Delivery Systems Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.1.12.3.1    India Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.12.4    India Transdermal Drug Delivery Systems Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.1.13   South Korea: Transdermal Drug Delivery Systems Market – Revenue and Forecast to 2027 (USD Million)

10.1.13.1    South Korea: Transdermal Drug Delivery Systems Market – Revenue and Forecast to 2027 (USD Million)

10.1.13.2    South Korea Transdermal Drug Delivery Systems Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.13.2.1    South Korea Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.13.2.2    South Korea Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.13.3    South Korea Transdermal Drug Delivery Systems Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.1.13.3.1    South Korea Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.13.4    South Korea Transdermal Drug Delivery Systems Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.1.14   Australia: Transdermal Drug Delivery Systems Market – Revenue and Forecast to 2027 (USD Million)

10.1.14.1    Australia: Transdermal Drug Delivery Systems Market – Revenue and Forecast to 2027 (USD Million)

10.1.14.2    Australia Transdermal Drug Delivery Systems Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.14.2.1    Australia Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.14.2.2    Australia Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.14.3    Australia Transdermal Drug Delivery Systems Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.1.14.3.1    Australia Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.14.4    Australia Transdermal Drug Delivery Systems Market, by End User – Revenue and Forecast to 2027 (USD Million)

11.       Impact of COVID-19 Pandemic on Asia Pacific Transdermal Drug Delivery System Market

11.1      Asia Pacific: Impact assessment of COVID-19 Pandemic

12.       Company Profiles

12.1      Novartis AG

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      GlaxoSmithKline plc.

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      MYLAN N.V.

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      Luye Pharma Group

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Hisamitsu Pharmaceutical Co ,Inc.

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

13.       Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

 


LIST OF TABLES

Table 1.            Asia Pacific Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 2.            Asia Pacific Transdermal Drug Delivery System Market, by Application– Revenue and Forecast to 2027 (USD Million)

Table 3.            Asia Pacific Transdermal Drug Delivery System Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 4.            Asia Pacific Transdermal Drug Delivery Systems Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 5.            Asia Pacific Transdermal Patches Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 6.            Asia Pacific Transdermal Semisolids Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 7.            Asia Pacific Transdermal Drug Delivery Systems Market, by Application– Revenue and Forecast to 2027 (USD Million)

Table 8.            Asia Pacific Hormonal Application Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 9.            Asia Pacific Transdermal Drug Delivery Systems Market, by End User– Revenue and Forecast to 2027 (USD Million)

Table 10.          China Transdermal Drug Delivery Systems Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 11.          China Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 12.          China Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 13.          China Transdermal Drug Delivery Systems Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 14.          China Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 15.          China Transdermal Drug Delivery Systems Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 16.          Japan Transdermal Drug Delivery Systems Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 17.          Japan Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 18.          Japan Transdermal Semisolids Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 19.          Japan Transdermal Drug Delivery Systems Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 20.          Japan Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 21.          Japan Transdermal Drug Delivery Systems Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 22.          India Transdermal Drug Delivery Systems Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 23.          India Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 24.          India Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 25.          India Transdermal Drug Delivery Systems Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 26.          India Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 27.          India Transdermal Drug Delivery Systems Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 28.          South Korea Transdermal Drug Delivery Systems Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 29.          South Korea Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 30.          South Korea Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 31.          South Korea Transdermal Drug Delivery Systems Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 32.          South Korea Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 33.          South Korea Transdermal Drug Delivery Systems Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 34.          Australia Transdermal Drug Delivery Systems Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 35.          Australia Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 36.          Australia Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 37.          Australia Transdermal Drug Delivery Systems Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 38.          Australia Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 39.          Australia Transdermal Drug Delivery Systems Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 40.          Glossary of Terms, Transdermal Drug Delivery System Market

 


LIST OF FIGURES

Figure 1.           Transdermal Drug Delivery System Market Segmentation

Figure 2.           Transdermal Drug Delivery System Segmentation – By Region

Figure 3.           Asia Pacific Transdermal Drug Delivery System Market Overview

Figure 4.           Transdermal Patches Segment Held Largest Share of Transdermal Drug Delivery System Market

Figure 5.           China Is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           Asia Pacific PEST Analysis

Figure 7.           Asia Pacific Transdermal Drug Delivery System Market – Revenue Forecast And Analysis – 2019- 2027

Figure 8.           Transdermal Drug Delivery System Market Revenue Share, by Type, 2019 and 2027 (%)

Figure 9.           Transdermal Patch: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)

Figure 10.        Drug-In-Adhesive Patches: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)

Figure 11.        Matrix Patches: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)

Figure 12.        Reservoir Membrane Patches: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)

Figure 13.        Microneedle Patches: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)

Figure 14.        Transdermal Semisolids: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)

Figure 15.        Gel: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)

Figure 16.        Sprays: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)

Figure 17.        Ointments: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)

Figure 18.        Transdermal Drug Delivery System Market, by Application, 2019 and 2027 (%)

Figure 19.        Cardiovascular Diseases: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)

Figure 20.        Central Nervous System Disorders: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)

Figure 21.        Pain Management: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)

Figure 22.        Hormonal Applications: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)

Figure 23.        Transdermal Estrogen Therapy: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)

Figure 24.        Testosterone Replacement: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)

Figure 25.        Other Applications: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)

Figure 26.        Transdermal Drug Delivery System Market, by End User, 2019 and 2027 (%)

Figure 27.        Hospitals and Clinics: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)

Figure 28.        Home Care Settings: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)

Figure 29.        Asia Pacific: Transdermal Drug Delivery System Market, by Key Country – Revenue (2019) (USD Million)

Figure 30.        Asia Pacific Transdermal Drug Delivery Systems Market Revenue and Forecast to 2027 (USD Million)

Figure 31.        Asia Pacific: Transdermal Drug Delivery Systems Market, by Country, 2019 & 2027 (%)

Figure 32.        China: Transdermal Drug Delivery Systems Market – Revenue and Forecast to 2027 (USD Million)

Figure 33.        Japan: Transdermal Drug Delivery Systems Market – Revenue and Forecast to 2027 (USD Million)

Figure 34.        India: Transdermal Drug Delivery Systems Market – Revenue and Forecast to 2027 (USD Million)

Figure 35.        South Korea: Transdermal Drug Delivery Systems Market – Revenue and Forecast to 2027 (USD Million)

Figure 36.        Australia: Transdermal Drug Delivery Systems Market – Revenue and Forecast to 2027 (USD Million)

Figure 37.        Impact of COVID-19 Pandemic In Asia-Pacific Country Markets

  1. Novartis AG
  2. Luye Pharma Group
  3. Mylan N.V.
  4. GlaxoSmithKline plc
  5. Hisamitsu Pharmaceutical Co., Inc
  • To understand the Asia Pacific transdermal drug delivery system market landscape and identify market segments that are most likely to guarantee a strong return
  • To stay ahead in comprehending the ever-changing competitive landscape of the Asia Pacific transdermal drug delivery system market
  • To efficiently plan M&A and partnership deals in the Asia Pacific transdermal drug delivery system market by identifying market segments with the most promising probable sales
  • To help take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segments in the Asia Pacific transdermal drug delivery system market
  • To obtain market revenue forecast from 2020 to 2027 in various segments of the Asia Pacific transdermal drug delivery system
TIPRE00013002
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing